The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations

SIMPLE SUMMARY: Cellular proliferation is a central determinant of breast cancer recurrence risk and response to chemotherapy. The discovery of the Ki-67 antibody by Dr. Johannes Gerdes in 1983, with the observation that Ki-67 immunohistochemical expression was only present in proliferating cells, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Finkelman, Brian S., Zhang, Huina, Hicks, David G., Turner, Bradley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913317/
https://www.ncbi.nlm.nih.gov/pubmed/36765765
http://dx.doi.org/10.3390/cancers15030808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913317/
https://www.ncbi.nlm.nih.gov/pubmed/36765765
http://dx.doi.org/10.3390/cancers15030808

Ejemplares similares